Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Last Funding Type:
Secondary Market
Funding Status:
Private Equity
Headquarters:
South San Francisco, California, United States
Founded Date:
2015-01-01
Last Funding Date:
2022-09-28
Total Funding:
3500000000.0
Employee Number:
1001-5000
Number Of Exists:
4
Acquisitions Number:
Made Acquisitions
Estimated Revenue:
$100M to $500M
Investors Number:
6
Industry:
End-to-End Drug Development